Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

SOPHiA GENETICS (SOPH) Work In Process (2020 - 2021)

SOPHiA GENETICS's Work In Process history spans 2 years, with the latest figure at $1.3 million for Q4 2021.

On a quarterly basis, Work In Process rose 84.21% to $1.3 million in Q4 2021 year-over-year; TTM through Dec 2021 was $1.3 million, a 84.21% increase, with the full-year FY2021 number at $1.3 million, up 84.21% from a year prior.
Work In Process hit $1.3 million in Q4 2021 for SOPHiA GENETICS, up from $722000.0 in the prior quarter.
Over the last five years, Work In Process for SOPH hit a ceiling of $1.3 million in Q4 2021 and a floor of $722000.0 in Q4 2020.